Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CPC and Zinc Lactate Mouthwash for Reducing Bacteria in Dental Aerosols
NCT07880509Phase 4Not yet recruiting
- Sponsor
- Colgate-Palmolive
- Start
- Oct 2026
- Primary completion
- Dec 2026
01
Overview
Phase 4, randomised, double-blind trial of cetylpyridinium chloride and Zinc lactate (4 arms), sponsored by Colgate-Palmolive. Primary endpoint: Total Viable Bacterial Colony-Forming Units in Dental Aerosols. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
cetylpyridinium chlorideZinc lactate
Beyond the preview
Go deeper on NCT07880509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07880509.